The Compound and Friends cover image

The Next Circle IPO, Ric Edelman on Crypto Allocations, Novo Nordisk vs Hims, Dumbflation

The Compound and Friends

00:00

Partnerships and Challenges in the Pharmaceutical and Tech Industries

This chapter examines the abrupt end of the partnership between Novo Nordisk and HIMSS due to concerns over marketing practices and safety risks. It highlights the volatility within corporate collaborations in both the pharmaceutical and tech sectors, with a focus on implications for regulatory compliance and consumer trust. The discussion also covers the landscape of autonomous vehicles, illustrating partnerships like that of Waymo and Uber, and the challenges posed by new technologies in urban environments.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app